These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 32471499)

  • 1. CCL2/CCR2 signaling in cancer pathogenesis.
    Hao Q; Vadgama JV; Wang P
    Cell Commun Signal; 2020 May; 18(1):82. PubMed ID: 32471499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.
    Zhang J; Patel L; Pienta KJ
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):41-8. PubMed ID: 20005149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.
    Semple BD; Kossmann T; Morganti-Kossmann MC
    J Cereb Blood Flow Metab; 2010 Mar; 30(3):459-73. PubMed ID: 19904283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of CCL2-CCR2 Axis in the Tumor Microenvironment.
    Kadomoto S; Izumi K; Mizokami A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma.
    Wang Z; Xie H; Zhou L; Liu Z; Fu H; Zhu Y; Xu L; Xu J
    Oncotarget; 2016 Aug; 7(32):51525-51534. PubMed ID: 27409666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
    He S; He S; Chen CH; Deborde S; Bakst RL; Chernichenko N; McNamara WF; Lee SY; Barajas F; Yu Z; Al-Ahmadie HA; Wong RJ
    Mol Cancer Res; 2015 Feb; 13(2):380-90. PubMed ID: 25312961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury.
    Jablonski CL; Leonard C; Salo P; Krawetz RJ
    J Orthop Res; 2019 Dec; 37(12):2561-2574. PubMed ID: 31424112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the CCL2-CCR2 signaling axis in cancer metastasis.
    Lim SY; Yuzhalin AE; Gordon-Weeks AN; Muschel RJ
    Oncotarget; 2016 May; 7(19):28697-710. PubMed ID: 26885690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
    Lu Y; Chen Q; Corey E; Xie W; Fan J; Mizokami A; Zhang J
    Clin Exp Metastasis; 2009; 26(2):161-9. PubMed ID: 19002595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine.
    Pozzi S; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2024 Jun; 209():115318. PubMed ID: 38643840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.
    Moadab F; Khorramdelazad H; Abbasifard M
    Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
    Covino DA; Sabbatucci M; Fantuzzi L
    Curr Drug Targets; 2016; 17(1):76-110. PubMed ID: 26687605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
    Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
    Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CCL2-CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells.
    Natsagdorj A; Izumi K; Hiratsuka K; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Shigehara K; Nakata H; Mizokami A
    Anticancer Res; 2023 Jun; 43(6):2561-2569. PubMed ID: 37247914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
    Xu M; Wang Y; Xia R; Wei Y; Wei X
    Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
    Iwamoto H; Izumi K; Mizokami A
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CCR2 in orthodontic tooth movement.
    Taddei SR; Andrade I; Queiroz-Junior CM; Garlet TP; Garlet GP; Cunha Fde Q; Teixeira MM; da Silva TA
    Am J Orthod Dentofacial Orthop; 2012 Feb; 141(2):153-60. PubMed ID: 22284282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CCL2/CCR2 signaling activation contributes to tooth movement pain].
    Yang Z; Luo W; Fu R; Tan Y; Yuan L; Fang B
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Aug; 49(8):500-5. PubMed ID: 25351225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.